Holocene Advisors LP Cuts Position in Option Care Health, Inc. (NASDAQ:OPCH)

Holocene Advisors LP lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 20.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,906,723 shares of the company's stock after selling 505,011 shares during the quarter. Holocene Advisors LP owned approximately 1.12% of Option Care Health worth $59,680,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also modified their holdings of the company. Atom Investors LP bought a new stake in shares of Option Care Health in the 3rd quarter worth about $485,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Option Care Health during the third quarter valued at approximately $439,000. Bellevue Group AG lifted its position in Option Care Health by 16.8% during the third quarter. Bellevue Group AG now owns 1,654,878 shares of the company's stock valued at $51,798,000 after acquiring an additional 237,999 shares during the last quarter. Martingale Asset Management L P acquired a new position in Option Care Health during the 3rd quarter valued at approximately $287,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Option Care Health by 84.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 70,119 shares of the company's stock valued at $2,195,000 after purchasing an additional 32,142 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Performance

OPCH traded down $0.46 during trading on Tuesday, hitting $23.66. The stock had a trading volume of 1,328,501 shares, compared to its average volume of 1,551,896. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63. The firm has a market capitalization of $4.03 billion, a P/E ratio of 20.27, a PEG ratio of 2.46 and a beta of 1.33. The company's 50-day moving average price is $26.84 and its 200 day moving average price is $28.87.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.64% of the company's stock.

Analyst Ratings Changes

Several research firms have issued reports on OPCH. Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Barrington Research dropped their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Jefferies Financial Group cut shares of Option Care Health from a "buy" rating to a "hold" rating and dropped their price target for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities lifted their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Finally, Truist Financial decreased their price target on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $30.83.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.